WOOF, FIVE and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 9th, 202

Humana affirms its guidance of at least $9.00 in adjusted earnings per common share ("Adjusted E

Oscar Health's ACA marketplace expansion fuels growth prospects, but subsidy uncertainty, rising med

Oscar Health, Inc. (OSCR) reached $32.91 at the closing of the latest trading day, reflecting a +1.7

Prudential Financial, Assurant, Oscar and Horace Mann have been highlighted in this Industry Outlook

WOOF, FIVE and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 7th, 202

Better pricing, product redesigns and technological advancements are expected to aid Zacks Multiline

Valuation Assessment of Oscar Health Inc (OSCR)On October 05, 2026, Oscar Health Inc (OSCR) shares r

Oscar Health's premium valuation reflects surging membership, improving profitability, a scalable te

Oscar Health (NYSE:OSCR) held its second-quarter earnings conference call on Thursday. Below is the

WOOF, FIVE and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 5th, 202

Oscar Health, Inc. (OSCR) reached $29.9 at the closing of the latest trading day, reflecting a -3.05

The healthcare sector has performed fairly well so far in 2026 due to several factors: GLP-1 medicat

Oscar Health is rated a buy, targeting a $45-$49 fair value, driven by scalable growth and margin ex

WOOF, FIVE and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 25th,

Oscar Health's profit rebound faces a test as rising medical spending and a larger member base threa

Oscar Health (OSCR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism a

OSCR, SNDR and TFII made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 23rd

Oscar Health is upgraded to Strong Buy with a new $45 fair value, reflecting raised 2026–2029 earnin

LCUT, FIVE and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 23rd,

Oscar Health, Inc. (NYSE: OSCR - Get Free Report) Director Vanessa Ames Wittman sold 25,000 shares o

Insurance stocks can be well positioned in a higher interest rate environment, particularly because

Raymond James analyst John Ransom maintains Oscar Health (NYSE:OSCR) with a Outperform and raises

B of A Securities analyst Adam Ron maintains Oscar Health (NYSE:OSCR) with a Underperform and rai

Shares of Oscar Health are trading higher Thursday as Wall Street analysts raised price targets foll

Stephens & Co. analyst Raj Kumar reiterates Oscar Health (NYSE:OSCR) with a Equal-Weight and

Barclays analyst Andrew Mok maintains Oscar Health (NYSE:OSCR) with a Overweight and raises the p

Baird analyst Michael Ha maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price t

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

As previously announced, Oscar Health, Inc. (the "Company" or "Oscar") will host its

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Wells Fargo analyst Stephen Baxter maintains Oscar Health (NYSE:OSCR) with a Equal-Weight and rai

UBS analyst Jonathan Yong maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price

Barclays analyst Andrew Mok maintains Oscar Health (NYSE:OSCR) with a Overweight and raises the p

Oscar Health (OSCR) beat Q2 earnings with $4.88B revenue, but shares fell on expected ACA membership

Oscar Health (NYSE:OSCR) affirms FY2026 sales outlook from $18.700 billion-$19.000 billion to $18.70

     As of June 30, Effectuated Membership by Offering2026 2025 Individual and Small Group (1)2,963,

Oscar Health (NYSE:OSCR) reported quarterly earnings of $1.10 per share which beat the analyst conse

Elevance Health (ELV) beats Q2 expectations but triggers a broader managed-care selloff after a cons

Barclays analyst Andrew Mok upgrades Oscar Health (NYSE:OSCR) from Equal-Weight to Overweight and

Oscar Health shares reach fresh 52-week highs Wednesday, extending an 80% YTD rally after Monday&#39

Oscar Health shares surged after the company reaffirmed its 2026 outlook and provided a business upd

Stocks had mixed performance on Thursday, Dow Jones up 793 points while Nasdaq down 232 points. Rumb

UBS analyst Jonathan Yong maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price

Barclays analyst Andrew Mok maintains Oscar Health (NYSE:OSCR) with a Equal-Weight and raises the

Baird analyst Michael Ha maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price t

Wall Street analysts changed outlook on top names. Check out analyst rating changes, including upgra